Pages that link to "Item:Q1713282"
From MaRDI portal
The following pages link to Optimal control of non-autonomous SEIRS models with vaccination and treatment (Q1713282):
Displaying 17 items.
- On application of optimal control to SEIR normalized models: pros and cons (Q335250) (← links)
- A switched multicontroller for an SEIADR epidemic model with monitored equilibrium points and supervised transients and vaccination costs (Q1713833) (← links)
- Vaccination and treatment as control interventions in an infectious disease model with their cost optimization (Q2005066) (← links)
- Global stability of a Caputo fractional SIRS model with general incidence rate (Q2035607) (← links)
- Dynamical behaviors and optimal control problem of an \textit{SEIRS} epidemic model with interventions (Q2048982) (← links)
- Optimal control of behaviour and treatment in a nonautonomous SIR model (Q2113741) (← links)
- Mathematical modeling and control of the cell dynamics in leprosy (Q2130711) (← links)
- New aspects of time fractional optimal control problems within operators with nonsingular kernel (Q2180308) (← links)
- Optimal control of a fractional order epidemic model with application to human respiratory syncytial virus infection (Q2201401) (← links)
- On optimal singular controls for a general SIR-model with vaccination and treatment (Q2257912) (← links)
- Optimal control of the customer dynamics based on marketing policy (Q2323467) (← links)
- A SEIR model for control of infectious diseases with constraints (Q2514404) (← links)
- About partial reachability issues in an SEIR epidemic model and related infectious disease tracking in finite time under vaccination and treatment controls (Q2662991) (← links)
- Analysis of SEIR epidemic patch model with nonlinear incidence rate, vaccination and quarantine strategies (Q2672412) (← links)
- Optimal Control for an SEIR Epidemic Model with Nonlinear Incidence Rate (Q4967129) (← links)
- Optimizing the quarantine cost for suppression of the COVID-19 epidemic in Mexico (Q5042031) (← links)
- A MODEL OF THE OPTIMAL IMMUNOTHERAPY OF PSORIASIS BY INTRODUCING IL-10 AND IL-22 INHIBITORS (Q5130470) (← links)
